Beryl Drugs is not listed on NSE
AnnouncementsBeryl Drugs: Board to consider dividend
AnnouncementsBeryl Drugs: Outcome of board meeting
52 Week HighBeryl Drugs has hit a 52wk high of Rs 48.00 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 41.90 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 36.00 on BSE
No recommendations so far.What's your call on Beryl Drugs today?
|Company Name||Last Price||%
|Dr Reddys Labs||2710.55||-0.86||2939.80||2140.35||46,170.16|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 910.00 34.81%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Beryl Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 11.66 crore.The company has reported a standalone sales of Rs 2.80 crore and a Net Loss of Rs -0.09 crore for the quarter ended Mar 2014.
The company management includes Sanjay Sethi - Chairman & Managing Director, Sudhir Sethi - Whole Time Director, Sunil Jain - Director, Hemant Jain - Director, Avinash Sharma - Director, Bagachand Jain - Director.
It is listed on the BSE with a BSE Code of 524606.
Its Registered office is at 133, Kanchan Bag , Indore,Madhya Pradesh - 452001.
Their Registrars are Adroit Corporate Service (P) Ltd.